All In Biotech

Free tool

FAERS Monitor: Dexilant

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022287 or its brand name (Dexilant, Dexlansoprazole). Reports on generic versions are filed under their own applications.

Reports

41,708

Serious

33,723

81% of reports

Hospitalization

7,317

Death reported

3,737

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • chronic kidney disease16,102
  • acute kidney injury7,811
  • renal failure6,722
  • end stage renal disease4,888
  • renal injury4,339
  • drug ineffective2,627
  • fatigue2,442
  • off label use2,345
  • nausea2,244
  • tubulointerstitial nephritis2,191
  • diarrhoea2,006
  • headache1,972
  • pain1,965
  • death1,887
  • dyspnoea1,652

Reports by year received

View as table
YearReports
20081
20092
2010114
2011375
2012710
2013707
2014989
20151,641
20162,105
20171,672
201813,439
20197,819
20202,724
20212,416
20221,915
20231,556
20241,362
20251,292
2026869

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,012,451 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
end stage renal diseaseSignal4,888184.2178.5652,603
chronic kidney diseaseSignal16,102135.3133.41,698,139
renal injurySignal4,33986.183.4311,908
tubulointerstitial nephritisSignal2,19166.663.8125,122
acute kidney injurySignal7,81127.126.5187,441
renal failureSignal6,72226.826.2159,708
pain1,9651.61.5472
headache1,9721.61.5441
fatigue2,4421.61.5543
diarrhoea2,0061.61.5425
dyspnoea1,6521.51.4257
nausea2,2441.41.4301
off label use2,3451.41.3223
death1,8871.11.119
drug ineffective2,6271.01.00

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.